López-Jornet P, Camacho-Alonso F. Comparison of pain and swelling after removal of
oral leukoplakia with CO2 laser and cold
knife: A randomized clinical trial. Med Oral Patol
Oral Cir Bucal. 2013 Jan 1;18 (1):e38-44.
doi:10.4317/medoral.17960
http://dx.doi.org/doi:10.4317/medoral.17960
|
1. Van der Waal I, Axell
T. Oral leukoplakia: a proposal for uniform
reporting. Oral Oncol.
2002;38:521-26. |
||||||
|
|
||||||
|
2. Van der Waal I. Potentially malignant
disorders of the oral and oropharyngeal mucosa;
present concepts of management. Oral Oncol. 2010;46:423-5. |
||||||
|
|
||||||
|
3. Kramer IRH, Lucas RB, Pindborg JJ, Sobin LH. WHO Collaborating Centre for Oral Precancerous
Lesions. Definition of leukoplakia and related
lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978;46:518-39. |
||||||
|
|
||||||
|
4. Proia NK, Paszkiewicz
GM, Nasca MA, Franke GE, Pauly JL. Smoking and smokeless tobacco-associated human buccal cell mutations and their association with oral
cancer—a review. Cancer Epidemiol Biomarkers Prev.
2006;15:1061-77. |
||||||
|
|
||||||
|
5. Axell T, Pindborg
JJ, Smith CJ, Van der Waal I. Oral white lesions
with special reference to precancerous and tobacco related lesions:
conclusions of an international symposium held in Uppsala, Sweden, May 18-21
1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med. 1996;25:49-54. |
||||||
|
|
||||||
|
6. Lodi G, Porter S. Management of potentially malignant disorders:
evidence and critique. J Oral Pathol Med. 2008;37:63-9. |
||||||
|
|
||||||
|
7. Poveda-Roda R, Bagan
JV, Jiménez-Soriano Y, Díaz-Fernández
JM, Gavaldá-Esteve C. Retinoids
and proliferative verrucous leukoplakia
(PVL). A preliminary study. Med Oral Patol Oral Cir
Bucal. 2010;15:e3-9. |
||||||
|
|
||||||
|
8. Ishii J, Fujita K, Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol. 2003;39:759-69. |
||||||
|
|
||||||
|
9. Vedtofte P, Holmstrup
P, Hjorting-Hansen E, Pindborg
JJ. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg.
1987;16:656-64. |
||||||
|
|
||||||
|
10. Chandu A, Smith AC. The use of CO2 laser
in the treatment of oral white patches: outcomes and factors affecting
recurrence. Int J Oral Maxillofac
Surg. 2005;34:396-400. |
||||||
|
|
||||||
|
11. Chiesa F, Sala L,
Costa L, Moglia D, Mauri
M, Podrecca S, et al. Excision of oral leukoplakias by CO2 laser on an out-patient basis: a
useful procedure for prevention and early detection of oral carcinomas. Tumori. 1986;72:307-12. |
||||||
|
|
||||||
|
12. Chu FW, Silverman S Jr, Dedo HH. CO2 laser treatment of oral leukoplakia.
Laryngoscope. 1988;98:125-30. |
||||||
|
|
||||||
|
13. Frame JW, Das Gupta AR, Dalton GA, Rhys Evans PH. Use of the
carbon dioxide laser in the management of premalignant lesions of the oral
mucosa. J Laryngol
Otol. 1984;98:1251-60. |
||||||
|
|
||||||
|
14. Flynn MB, White M, Tabah RJ. Use of
carbon dioxide laser for the treatment of premalignant lesions of the oral
mucosa. J Surg
Oncol. 1988;37:232-4. |
||||||
|
|
||||||
|
15. Roodenburg JL, Panders AK, Vermey A. Carbon dioxide laser surgery of oral leukoplakia. Oral Surg Oral Med
Oral Pathol. 1991;71:670-4. |
||||||
|
|
||||||
|
16. Ishii J, Fujita K, Munemoto S, Komori T. Management of oral leukoplakia
by laser surgery: relation between recurrence and malignant transformation
and clinicopathological features. J Clin Laser Med Surg. 2004;22:27-33. |
||||||
|
|
||||||
|
17. Pandey M, Thomas G, Somanathan
T, Sankaranarayanan R, Abraham Ek,
Jacob BJ, et al. Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala,
India. Oral Oncol.
2001;37:103-9. |
||||||
|
|
||||||
|
18. Holmstrup P, Vedtofte
P, Reibel J, Stoltze K.
Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42:461-74. |
||||||
|
|
||||||
|
19. Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg.
2001;30:49-53. |
||||||
|
|
||||||
|
20. Schoelch ML, Sekandari
N, Regezi JA, Silverman S Jr. Laser management of
oral leukoplakias: a follow-up study of 70
patients. Laryngoscope. 1999;109:949-53. |
||||||
|
|
||||||
|
21. Thomson PJ, Wylie J. Interventional laser surgery: an effective
surgical and diagnostic tool in oral precancer
management. Int J Oral Maxillofac
Surg. 2002;31:145-53. |
||||||
|
|
||||||
|
22. Van der Hem PS, Nauta JM Van der Wal
JE, Roodenburg JL. The results of CO2 laser
surgery in patients with oral leukoplakia: a 25 year follow up. Oral
Oncol. 2005;41:31-7. |
||||||
|
|
||||||
|
23. Schepman KP, Van der
Meij EH, Smeele LE, Van der Waal, I. Malignant transformation of oral leukoplakia: a follow up study of a hospital-based
population of 166 patients with oral leukoplakia
from The Netherlands. Oral Oncol. 1998;34:270-5. |
||||||
|
|
||||||
|
24. Einhorn J, Wersall
J. Incidence of oral carcinoma in patients with leukoplakia
of the oral mucosa. Cancer. 1967;20:2189-93. |
||||||
|
|
||||||
|
25. Chiesa F, Tradati N, Sala, L, Costa L, Podrecca
S, Boracchi P, et al. Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg. 1990;16:177-80. |
||||||
|
|
||||||
|
26. Villarreal-Renedo PM, Monje-Gil F, Junquera-Gutiérrez LM, De Vicente-Rodríguez
JC, Morillo-Sánchez AJ. Treatment of oral and oropharyngeal
epidermoid carcinomas by means of CO2 laser. Med Oral. 2004;9:168-75. |
||||||
|
|
||||||
|
|
||||||